(Q51914746)

17 April 2018

title

Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. (English)

1 reference

17 April 2018

1 reference

Federica Varsaldi

1

1 reference

17 April 2018

Gianluca Miglio

2

1 reference

17 April 2018

Maria Gabriella Scordo

3

1 reference

17 April 2018

Marja-Liisa Dahl

4

1 reference

17 April 2018

Laura Maria Villa

5

1 reference

17 April 2018

Aldo Biolcati

6

1 reference

17 April 2018

Grazia Lombardi

7

1 reference

17 April 2018

publication date

15 July 2006

1 reference

17 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

17 April 2018

volume

62

1 reference

17 April 2018

issue

9

1 reference

17 April 2018

page(s)

721-726

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1007/s00228-006-0168-1

exact match

0 references

cites work

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0168-1

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0168-1

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0168-1

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

21 January 2018

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

12 December 2020

Donepezil use in Alzheimer disease

1 reference

12 December 2020

Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection

1 reference

12 December 2020

Utilization of human liver microsomes to explain individual differences in paclitaxel metabolism by CYP2C8 and CYP3A4.

1 reference

12 December 2020

Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

12 December 2020

1 reference

12 December 2020

Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR

1 reference

12 December 2020

No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.

1 reference

12 December 2020

Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4

1 reference

12 December 2020

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

1 reference

12 December 2020

No association between familial Alzheimer disease and cytochrome P450 polymorphisms.

1 reference

12 December 2020

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

12 December 2020

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

1 reference

12 December 2020

Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication.

1 reference

12 December 2020

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

12 December 2020

Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

1 reference

12 December 2020

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

12 December 2020

Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study

1 reference

12 December 2020

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.

1 reference

12 December 2020

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

1 reference

12 December 2020

Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

10.1007/S00228-006-0168-1

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

16845507

1 reference

17 April 2018